Design Therapeutics (DSGN) Non-Current Assets (2020 - 2026)

Design Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 11.43% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $11.6 million (down 31.54% YoY), while the FY2025 annual figure was $2.4 million, down 40.32% from the prior year.
• Non-Current Assets came in at $3.4 million for Q1 2026 at Design Therapeutics, up from $2.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $6.2 million in Q2 2022 to a low of $2.4 million in Q4 2025.
• A 5-year average of $4.6 million and a median of $4.9 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 4830.0% in 2022 and tumbled 40.32% in 2025, its largest moves.
• Design Therapeutics' Non-Current Assets stood at $6.0 million in 2022, then retreated by 15.94% to $5.1 million in 2023, then slipped by 19.89% to $4.1 million in 2024, then sank by 40.32% to $2.4 million in 2025, then surged by 40.26% to $3.4 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $3.4 million, $2.4 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison